(1) Immunology : General Principles . 2008 .

. ..

, : 1- ; $< 7 14 1, " I 1 P 1" , 1 " =1- ; 34(

:
. Nonspecific (Innate) ( " # $% )
. Specific ( ) '

:
*+ ,- . / , #0 ( ) $% (
: 7 (8 34( 156 " , ," 2 ( ) -1 "
5 ,; <#. 7 , =, , 5 Pneumonia 91 : 4 : " .!
.@ $ , ?=, 8 ): ,; $ , =,>
.A $B ?, ," 15 8 C * : $ " .#
) $B 1 8 1 :,9 1 " -1 , ," : ' & .%
$B -1" F; . D E1 -1 , ; 24
. =11 : G
, ; ) ,- . / , #0 #0 +. , : )* & .(
. ? H" 2 4 G 7 @ 1#- 8 $ E8
: " 34( (8 : , -& .+
, * : ,- I ,; F ; " 7 ( : Opsonins . ' / .a
8 ( : +) , ,-8 8 : ( # 34( 7 " :" , ,"
. 1$ : J108 , , 8 ) "< : A"
51 " L ) K ... @ " I, , * 8 ( : Lysozyme 0 0 .b
51 E8 $ , ?5 ) # ( ) 1M ?$0
. ( 51 N- =, ?=1 I , 7G "
7 : 1 ( : The Complement System * 1 .c
A1" L O" I# G 34( @ + ; ) B "
:?5 )= L 7 ? + =1 5 : 1#->
. (7 N - @"$ ) =11 =1 5 : A1" L G C3 :, 4 -
. ; @84 @ $ L G C2 , , 4 -

- -
 (1) Immunology : General Principles . 2008 .

: ( 1# Q A 1; "< -
. C1 8, E4 : Classical Pathway E,
. C3 8, E4 : Alternate Pathway ,
F,; < 8 , 47 " # 7 : 4G C1 =1 " % * -
4() ) E, 2 < 8 , 47 -<0 7 8 , 4 8 , Q
. (C4 ) C2 =1 "
7- 1; G 24 +1 C9 C1 1 ( " (,, 1$ -
. C3 C2 C4 C1 :
. (,- ,-) ," Q 1# E, "<
: ( =1 (8 7 "< ," >*<
@4 F ; C567 4 C5a ) C3a 1$ " ( : Chemotaxis , - 231 & .a
. @7 > J :,,
, 0 156 C5a ) C3a 1$ " ( : Anaphylotoxin $,* 3 .b
E,6 E4 7 5 Vasoactive amines ? 9 "< : . Q # E,6
(=1 1 A 7 8 L ). :>, " I 9 I F ,; : 1 " 4 < =, *
:>, " :" I ,; F ;' C3b < U ( : Immune adherence $ * 5 .c
. " (, 0 34( V# =, C3b : # 9 0
. ( C9 C5 ) "< 1$ " ( : 6 & .d

: Cellular Factors >*<

34( , 1M : 9 * " 7 0 34( * : Macrophages 7I

: : #0 Q 7 " 4( ) J =, , 8 =, ;
. Chemotaxis P,7 @ 4 > .
. 7# ," Attachment Q $ > .'
. Phagosome : < # ( .) / > .W
.N @1 7G " 0 ,
: 4( 7<9 U (8 ) (1 ,
. =,9 * : ,- * A
. 7 8 : ,- : 5 '

. C7 C6 C5 " C567 /.../ 9 @4 ; C3a 15 J 8 C5a /.../ AX1; 8 " C3 " C3 1

. "< 31 , - =* : (# 1 " C3b 2
- -
 (1) Immunology : General Principles . 2008 .

.: < : ,- , W
. IL1 5 4 # : < " U Z
. C3 Fc : # (,- – ,- ) , " I ,; [
. PMN J : , , ?- 8 0 " II

, : 1- ; $<

: ( 9*- )
: 7
: Active .!
.V ," " $ 8 C 0. $ @ " # 8 (
: Passive " .#
. (IgG) 1 7 <# . 7 5 " # ?- 8 (
I1 1+ " # + N# F; + M N# Q 1# "$ 8
Q 1 ( " A1 + M N# 8
. Antitoxin

-,-
 (1) Immunology : General Principles . 2008 .

:
: #0 (a
. (Antibody , ,-. 7# ( E8) B.cells 9 0 #
: 0 (b
. (H 1 ) T.cells 9 0 #
: !" #$ %&& ' •
: ? - *7
: ; 0- 0<1 7!
.( U" ) : ,5 , L," 8 (1 # , ) O 1 @1 Thymus
: = ; / 0<1 '
. *7 H< *7 " N" . < ] ) < ," ) ;#
Lymphocytes < 0 ^ C 6 ( ( *1 ) . < N- . -
. ( U" 8 @1 =, " 9 : < ) =, " 9 : < )
5 / , *7 , > . . 51 :1 0, ,; -
.: > 1 ,," ? -1 ( " N" . E < ] $0 ) E < *7

<V íéÖæù]<íéËÛ×Ö]<ð^–Âù] V ÷æ_

: Thymus * * 7!
5 _ ; 1 ( ) $ P% ? ( ?1 , @"
. 7 , ; =, 7 1-
1 7U 0 ) Lymphocyte : < : 0 / 8 5 5 E ;
.( * ) # ; 0 ) Epithelial cells
P% 0, # 8 Cortex 1 # P5 : < I
.: < (: 1 7U 0 8
. 8 Z W ` 7 ; 1, 1, M : < A"
: E,6 ?5 ,; =, 19< , $9
.: < ,, D .
. , ,-. C D .'
. W N- . A1 #" .W

7 N- . 1* ; 34( # 5 7 $9 0 6 ( 8 ? N #. 3

. $9 ," ; :1 " 1 , , (=1 4 0) 9 0 A" . 1# 34( 8 ,

-1-
 (1) Immunology : General Principles . 2008 .

. < 0 * ?1 , @" E4 Thymosin * 1( =,M ]

:> ) 2 1 7#
( : M )1 # , B.cells 9 0 L % E4 (
. , U" L,"
( 1 5% L H , ,-. V- 1 5% C , , L $9 > 8 ,
( ) tuberculin 1 ; ; ( 0 ) 0 # <
. "# A 1

V íèçÞ^nÖ]<íéËÛ×Ö]<sŠßÖ]<V ^éÞ^m
: ?"
.? # H ?7 H B T 0 /* ?, # 7
. 7 $< 1 @ # Medulla # 1 # 8 P%
: & / 7#
. Encapsulated U<; # ; < ," ; ( ;#
: ? ( ?1 , ;# @"
. ( N1 ; 0 #; .a
. =, , 1 ; 0C .b
.: < ): ; ) : ; <$ C .c
. <$ ( . 7 31 , G 2 4 +1
: 1 ;8 @ A 8 @ ;# P %
. (: 1 ) ;# 1 / 1 ; ?N #+ : 2 -
- ) macrophages : " # ;# ; P% : 2 -
. Venous sinusoids , 1 @
I# = ; 11 > ? #1 H LG ) ;# 7 7 P9 U +1
.L , O"
: Uncapsulated @ / A B9 7%
? ?* ; K ... *7 H< -7 * 7 ] 34( I /*
. 0, I
.... 1 :; ) :* ) =,9 * =, < ] 7 58

-7-
 (1) Immunology : General Principles . 2008 .

: *+((( ((( )(((((

;# 1 , 1 7 1, M 5 U" < 0
.( < 0 1 " Q 1# ( ) ?17 8 Q1M , Q 1# 4( ) < ,"
< ] , 1 1 , 1M < 0 ( 0 1 5 /
Zb 'Z 1 , 4( 1 ) 9 0 7 +8 ( 'a) ? # (1 =1 M$ 0 ( < 0
Q# 34( 7 ; =1 0 E1 , ?1 1 ?1 1 1 0 34( G 4 ) 8 8
. > P1 U ? 8 ?1 , @"
P1" < 0 : < 1 ,," V 1 , 47 =* D9 $0 34( G N 58 8
. " 0- 8 : ,- 347 : ; : < I# 5 : ,-
:> ; ) 7 D E8 F,; 4 7 < ] A " V : < 1 , 4(
. #1 : 4 ( (1 , =1 4 0 @" F ; (A -1 ) / " )

=* 9 0 U" ; BP (B lymphocyte precursor) 9 0 " # 8 U;

I- F ;) < ," $ C10 L ( 1 1 ,) ;# $ 31 E , 1 , B.cells
. (, " #; ;#
C10 5 ?, =, , P9 U 40% * 2 ( $ 1 , 1 TP (T lymphocyte precursor) 9 0 " # 8
. 7 E* 1 0, I- F; < ," $ ; (B.cells` L ) (1 I L ;# $
. U" * ] 7 )H 7 H B.cells : ?4
.2 ( 9 0 " # F ; Bone marrow U" 7 ," H 0 7 T.cells 8

-9-
 (1) Immunology : General Principles . 2008 .

L U" P6 #; 9 0 L U" P6 0, P% =,1 =1, $ 8 2 < ,"

. Q , 1+ 1 ( 4( ?" # ) 9 0

: Cellular Immunity 6 *
" =1 2 ( 9 0 # ( 0 ? 14
: 7-1; 0 0,
Bacteria : Mycobacterium tuberculosis , Brucella ….
Fung : Candida , Histoplasma , Capsulatum .
Viruses : All .
Protozoa : Toxoplasma gondii , Malaria Plasmodias .
8 H 1< 7 8 I# 7 : 1< / 8 I 156 9 0 8 U;
. 0 0, 0, , H 1< 156 8I# > 9 0
A1; , ) ,- 7# * 7;# : T.cells 9 0 E ;
0 34( % V- ) 15 5 1 ; 7 F,; L G ,-
. (? ;> $< H1, P ) < 0 7 1 5%

-:-
 (1) Immunology : General Principles . 2008 .

: 0 C G 9 0
9 0 =, 78 . 7 <$ : TH (T-Helper) 0D ,* 6 7!
. (IgM M , : M I , ) Ab , ,-.
. P,7 0 1 5% 7 : T-Cytotoxic 6 9 ,* 6 7#
0 7 ; I 9 0 # 5 : TS (T-Suppressor) * - ,* 6 7%
. , ,-c
; L N- , ) ,- . A1" ," : -3 6 7(
. J108 =1 L A1"
F,; 4 8 ) , ,-c " #J U ; U " TH ) TS ? 8 U;
=, * F,; , ) , ,-. 0 E,6 24 G 7 E8 0 E8
. TS @ 1#- D : M
8 ?=1 P,7 N- I# ,- -1; T.cell 9 0
) 1 1 ): < : - Cytokines : = 4 *1 #
. 1
Z
: (1 , , 4 " 34(
. 51 =, - " 7 ' . J108 : < ) ) :>," ) : - ; @4
. " 1; , * Z . < 0 = ,( 0 W
.: < 18 ; d . A" =1 ( I [
., 7 < b . B f H ; e

: Humoral Immunity /6 *
, " ) , 9 P $ =, , ,-. # ( •
. B.cells 9 < 0 91
. Plasma cells 1 $ 0 *1< "< 1 9* * 8 :4 : 1 ( , ,-. 34(
. IgG – IgA – IgM – IgE – IgD : P1;. , ,-. 34( =,
V<íéÂ^ß¹]<
íéÂ^ß¹]< ]‚•ù]<àÂ<ìˆqçÚ<í
: 9 17 ;1 @ ; , 1 -
. 8 .
.( : M @ +8 - )E D – C' CB : 31 , E4 M .'

4
>*<

->-
 (1) Immunology : General Principles . 2008 .

: < <0 5 P% F; ) 1 + =1 ( : -
.J 8I , > 8 : < <0 .
: ( + M #" 7 G . P1; ?N / 8 =, 7 : 5 .'
IgE : K IgG : E + IgA : C <8
IgD : N , IgM : µ
. $< # 5 < <0 # 1 -
. 9 * # M 2 < -
. $< # M 9 * -
. =1 : ,- , L " 15 8 IgM : M J 8 ( IgG -
. " L 4G , : 1- ; $< : M g1 -
: $ & $, - ./* *

B.cells , 6 T.cells ,* 6
+ 5
. '0
: M , ,-8 I + 9 : < ,- $ I + IF " * E ")F *
d
EBV $; 9 . ?*9
+ C3 . ?*9

: 0/1 2 *
A1" , (T , B) =1 4 0 0 =1 . ,- A1" ,"
=1 : 1 F; ? ( ? ?1 , @" 0 34( G J108 =1 ,- H<
7 # =1 < ; ," =1 $ =1 , ,-. : 17U ? 5 ) , ,-.
. ,- , 8 1 5% $0

: 3 & &4 *
8, (Z W) 8 =, ," L G 1 ; . =1 ,- ; , : 1*95 .!
.A <0 > 8, 5 7 14 > 34( $ 8 / < 1> 1 1 7U A 1 .
G / J108 , ,-8 17U , ) IgM / U" 7 + ?=, , ,-. 34(
e
. . > 34( ) (I Q 1# 1 ,- / 24 , "

. Rosette Formation (P 10 : 1 (*) =1(* L E4 7 5

6
EBV = Epstein – Bar Virus
. IgG M 7 7 IgM M 7 , A1; . > 7

-B -
 (1) Immunology : General Principles . 2008 .

, ,-. J V$ 8 ; 1 =1 1 ; 21i 4 : = 1*95 .#

," 1 7U 8, , ,-. G Q ,- H< ; 4( ; 5)H @"$
IgG / , ,-. 34( ) . > 1$ 8 =1 7 14 $ =* =1
. 5 > 34( ) # =1 < ,

, ,-. J 8, 5 ) [ ," : > = 14 ) H 0 :8, . > 8 U;

. Wa , ,-. :< 0 A <0 >
. 17 15 8 , ># 7 " 1 =1 $ 7 1 IgM M (: . > ?4
. #: 1 , ?9 # A <0 "1 7 : 5 > 8

:: 1< 51 *

V Immunity to Bacteria Üém]†r×Ö<íÂ^ß¹] V ÷æ_

B 9 0 T 9 0 < > G 51 0, ,
. Macrophages
: = 1 /6 •
: 7 (8 =, , Q9 1# 7 , ; 51 ? ( ?1 , , ,-. @"
. P,7 0, 7" (* * ) 1 ,) 5 1 A" : < 4 ," 8I# .
. * * 0, ," #; 7-1" 51 1, : F ,; @ , ,-. .'
A 1; 4( ] ) 1$ A1; 7;# 51 : ,- I , ,-. ,; .W
1 J :,, @4 ? ( ?1 , @" (? :1 4) : 1
. "
: (# ) " , , ,-c 10j ( : Opsonization 7# .Z
. (J108 , 8 1$ 8 , ,-8 , ? 14

- BB -
 (1) Immunology : General Principles . 2008 .

: = 1 6 •
: ) 0 - 15 O" 8I# 51 N- ?, ( 0 -
@" 0 G : / 4( 5 < 1 : $ : 5 )(
51 $ 8 I# > , ,-. 8 F; ) #0 15 8 ? ( ?1 ,
. 0 -O"
.: < Q # ," 8 =1 51 8I# ; 9 0 -

V Immunity to Viruses l^‰æ!Ë×Ö<íÂ^ß¹] V ^éÞ^m

H DNA 8 RNA E ; 78 A" 7-" P 0 0 -: 1 < 15
: 7 58 ) ?" 5>
DNA Viruses :
a) Herpes . V (HSV) .
b) Pox Viruses : smallpox – cowpox .
c) Adeno Viruses : respiratory .
d) Papo Viruses : Warts .
RNA Viruses :
a) Arbo Viruses .
b) Ortho Viruses .
c) Paramyxo Viruses .
d) Rhabdo Viruses .
e) Picorna Viruses .

-B -
 (1) Immunology : General Principles . 2008 .

.( 0 #0 E8) T B 0 : 1< >

: /6 & " •
/ < 1> 1 IgG ` )I 8 ," A <0 > 8, 5: 1< > ," IgM ," I< 1
: 1 ,L : 1 < , ,-. # 1 ) J108 $ F ,; I ,. # #"
. (15 I 0 : 1< 0, , ,-. I .
.: 1< ," 1$ A1; .'
.: 1< " , .W
.,, F ,; I , ,-. ?4 ) E16 F ,; I E* 1 IgA ` .Z

: 6 •
, 0 0, I # > , ,-. 8 F; 1< : ,- ? ( ?1 , @" -
1 8 , =1 J108 0 1 8 I# : 1< 8 ) : 1< 70,
. E 0 C1 0 9
: ( 0 1 5% Q1# -
. PMN ` @4 : < g1# 8: 1< ; 0 I# .
.: 1< ; E,6 8 ; 9 0 I# .'
0 -: 1 < 15 I E4 1 1 > Q# 8 ; 0 34( I # .W
. 7 $ 1M 0 I

-B -
 (1) Immunology : General Principles . 2008 .

: Hypersensitivity States 567 8/9 :

.] 46 < / 8 =, 2 (
: ?5 ,; 7 P -8 ) / 8 I 18 ; #1 :> ; H " ,
.( " ; #1 ) Anaphylactic % / :& E .!
. Cytotoxic 0 / : = E .#
. Immune Complex ," :G = E .%
. Delayed Hypersensitivity f H ; :H E .(
: 7 P -8
. (Q1, D 0 ( ) 7 , ,-. 8 Stimulatory 7 :I 6 E .+
. 1< 8:I 9 E .J

V<Anaphylactic<ÑbjÖ]<V Ùæù]<ÅçßÖ]
< =1( U 34( # ) , % ; @ 8 IgE M I# -
*7 . ; =, Mast Cell , 0 V# ,- (IgE) ,-
: 7 (8 9 #9 Q # 2 4 E,6 ) , H< * 7 ) -7
. 7 (a
. SRSA (Slow Reaction Substance A) < 9# , (b
. Plasma Kinins : (c
( - D 9 I ,1 81 4) . Bradykinin & Kallidin (d
: E,6 -
. . I ' . 9 4 < =, *
. :- ; @4 Z .N : -" D W
. , 0 @; , [
. 1 E , #M- A <0 E,6 4(
D0 , ," > 4( L , E4 D0 ) Q% ; 5 1 , ," 7, D0 8 2 ( -
. Atopic %
: ( ,- 0, 24 , " , Q% ; 2 ( -
. k" Q% ' "- Q%
+. V# < , F,; # 11 1( U : " $K* .a
) * : ; ) I# 1 + Q :` 4( F,; =, ) 1
: =1$ 1( U

- B, -
 (1) Immunology : General Principles . 2008 .

. ; @7
.P.
.: $ A ,- Q ," F,; ,
F,; "1 " 5, ; 34( =, ) 1 8 =, @$ L A1" : " $K* .b
: < ( ) :1 ; +, 8 @ 1+ $ ) 5 ,- ; ," =,
: 31( U (8 ;. A"
=1 ; 4 ' . Bronchospasm $ ]
. Q 1* Z . H< Q - W
. 1 1 A <0 [
. 1 ] " 8@ " 5, ; " Q% -
.. 7 :,- + 1,8 + * 1 1, 7 N # ( 7 -. C " -
V Anaphylactoid-Reaction •
1 , IgE ` > % < ( 1 0. 8 F; % < % ,$ * @ -
.( 7 5) =,; 7 9 , #9 8)L
7 g1# 8 , 0 =1 156 % < ;# : 1 -
; , ; 7 Q # , Q% 7 :1M F,; , 8 ) : ; <$
8 4 F,; , 4 1j :> ; : :> ; 34( Lactose-Intolerance *
., 347 A1"
34( Q # @ 8 K ... . ) * 1< ) A A 5 "#. A" : 5 -
. , 0 #9
. 7 * 1 A 1; H J108 : 1 7- 1; E1 1 ; A1; : -

: (Wheal & Flare) Urticaria •

)2 5 N" . ,- D$ > F,; H ; =1( U ( , E1 F,; -
. k" Q% Q 1 8 ?,1< F,; ) * 1< ) A
8 F; ) :> ; ( E1 :> ; : L8 1 > " I- 8 @ -
. A1 8 ,1 @ E1 @ : 1 g1#

V Cytotoxic Antibody (]‚•ù^e<ëçפ]<ÜÛŠjÖ]<¼´<V êÞ^nÖ]<ÅçßÖ]

+8 =, : ,- L IgM IgG / , ,-. L# 4(
. 0

- B1 -
 (1) Immunology : General Principles . 2008 .

I ,- , ; 2 4 ) 0 +8 8 ] Adsorb ,- * , ;. A"
.] @ 10 F,; "< 2 4 )] * ,- 4(
: H ; #1 / 4( 5 . (8
, N1 ; : 1 ; #; F,; F ; : *3 5 ? .!
, ,-. 34( P ) N1 ; 0 V# 7 4 Auto Ab 4 , ,-.
.H < Q 1#
1 $ E,6 , =1 #0 : * 1 " : Good Paster *9 A 3 * .#
E, N M 7 , ,-8 , )@ P 1" 1 + ( * E
F< 2 4 @ @7 24 ] 1$ " "< 2 4 E 91 0
.= E,6 , ,

V Immune Complex<êÂ^ß¹]<‚Ïù]<V oÖ^nÖ]<ÅçßÖ]

] (,- – ,- , " P6 ) ," I- @ 4( 4. F,;
: 7 (8 =, , 58L ) "< 8 ," 7 : < @
A1; : * $ 8 F; ) : ," :* ,; : @7 .!
E,6 @ 1 1 , ," : ,- I ,; , ,-8
? -1 H ?4 ) : , " B ,; : @7 1$ 1 1;
. (L5 ,; 1 1 , 51 H ? 51
. 1 15 8 N @ $ E4 E* 7 ; @7 .#
: ," H ; #1 :> ; : U;
.: ," B : @7 E,6 :
. 9 M : @7 E,6 : 0
V<oÖ^nÖ] ÅçßÖ]<»<íè‚é×ÏjÖ]<løÂ^ËjÖ]
. Serum Sickness $ A1 ' . Arthus Reaction H 518 <
. ," A1 8 F,; E4 L < ( ) F,; : < H< 4(
:I = ;& * 71M
47 ? 8 ? H ; 1 ; , :; ,- ; ," < 4( F,;
< F,; E8) ] @10 ,- I ,- 4( ,; F ; ) L ; 8 ,-
. (] @10 L "- ;
7 > " 1 1$ "< ," ,- I ,- , ; ,"
.] @10 ?1 , * * : * 8 @" F ; @ 7 > J : , , @4

- B7 -
 (1) Immunology : General Principles . 2008 .

: >*< I = ; & * '@

.@ 1 ,- I ,- ,; 8 ," H 518 < F,; .
. 1 , ,-. # " # ; H 518 < .'
.6 # F ,; ," 15 8 ,- 8@ .W
1 ,- 24 , " ,- ; : Z W ," " :1M F,; .Z
. (: a ," =, < @M)
- J :,, g 1 ( H 518 < =1 4. F,; :1M .[
? 8 ? ( ?1 , @" * * : *8 8 . C1 0 ] , . ;
. F,; E4 , ; 10
b Z L5 ,; $ ,- ; : Z W ," H 518 < F,; : N 6;
. 'Z ' 0 N# I 1 5:
:I = ;& * . /6 O6
.N 1, # (,- ,-) ," .
. (E, 1 E8 C1 ) 1$ "< :," .'
. @4 =1, 7 .W
.: # ," I ,; J : , , @4 .Z
. :," I Neutrophils :>," .[
. Vasculitis 9 4. E,6 :>," 34( : 1 g1# " N 58 .d

: >*< Serum sickness & : ?" " &-) 72M

. * ,; : L
: Acute Serum Sickness & .a
Acute , ; @ 7 E,6 . P 0 I- , 1 , ,"
. Inflammation
.( l a P$ ) , ; ," A1 ; 4 # 5 ( $ A1
: 1* & *
m /m '[a) BSA8 E1 . =, ; ; (@ 1. =, ) 1 ; ;
) ) $< )@ 7 : 1 M F,; * =1 < ; ," )( ; *
. 1

BSA = Blood Serum Albumin 8

- B9 -
 (1) Immunology : General Principles . 2008 .

N, (,- ,-) ? ?, " BSA ` , ,-8 17U / % BSA ; ,"

V$ ; ," ;1 , ,-. ,* ; 1 M$ , " 4(
. 1$ A 1; ?1,
@ 1 :," 34( A" ) 1 , ," @M 1 E, ; ;
. <$ : 1 M L , ; @ @7 @ 1$ A1; :

:& 0 &-) .b
; 34( < ) 1U AM 1 ; @ 1+ 1 11 ; (
.1 ; 4( ,"
) 7 1 , ,- , 11 ( * $ A1 F ,; 7 "
.? ,- (@ 1. ) 1 : ; ; F;) ( ?- 8 (,- \ ,- ) 8
: > F; 8 5 5 1 : ; (!o ,7" 8 ) Dixon
; 7 , E8 BSA ` ; 11 @ > @ 1. 34( : N ; B* * 5 . .
. A1 7 , F,; > ?, ,-8 ] Tolerence
F,;q , " q , * ;q ?1 ? ?, " ] : - - N ; B* * 1 .'
. ?# ? 7 8 ?1 ? -1
:, * ," ] ,- 7 F,; 34( : = = 1 .W
( @ @7 ) $ F,; *1 :," 34( =, : ,-
. "- :," J1 8 Q% 9 - 17 ,0 : U;

V<oÖ^
oÖ^nÖ]<ØÂ^ËjÖ]<»<íée^ãjÖ÷]<íèƒù]<íé•]†Úc
. (,- =, * ) ,- – ,- : , "
. :," 1$ "< '
.A @4 1$ Q # W
.?9 "< : . Q # : ; <$ @ 10 Z
. . 4 < =, * [
.( $0 ) . 1, (,- – ,-) , " I- d
. @4 Q # 10j "< e
.J : , ," g 1 b
. * * : * Q # :>, " # :," ( 8) / l
.: * 34( # ] =1 0 #; a
. 1 < I-
.1 ; ; * V$ 8 : ,- =,; ; f I 1 '

- B: -
 (1) Immunology : General Principles . 2008 .

,. # 8 : @7 5 , . =1 $ A 1 8 , ," A1 8 : 1 4
. SLE * 7 ; 84 : 5 J108 =1 , " H =1#0 ? #? 40%

V Delayed Hypersensitivity<Øqû]<Œ^ŠvjÖ]<V Äe]†Ö]<ÅçßÖ]

. N# 17U ) 9 0 Q$ ( -
. e' Zb ," L 9 17U Tb g : 5 -

V Stimulating<êãéfßjÖ]<V ‹Ú^¤]<ÅçßÖ]
34( @ ( 7# 5 8 7 >) 1, : A1; 8 (IgG) M I# -
. L.A.T.Sl , , 1, =,M L 4( ) 1, > ;

: Auto Immunity ;2
. ,- I , V $ ) : 1 M A" ( -
. ] : L 0 # < ) 4 , ,-. : Q -
: < 9; '; -
@ I ,;> ; : Altration of selfproteins *3 . * R* (a
.( 1 I :,; 4 > ,- A 1; I # > : ,- A" 8 F ;) Haptens
: 58
. a alpha Methyl Dopa " @ , ; •
. Contact Dermatitis •
: Hidden Antigen 6 *9 (b
; ; > *7 *" =1( U 1 + <0 : ,- A"
. 4: 7% " 7 G A1" 11 > ?1U
: 5 8
Antisperm Ab P # , ,-8 C L $0 @ 7 : Spermatozoa P # •
. " F ,;
4 , ,-8 @ , Cataract , I1 * : Lens Proteins ," : 1 •
. J10. ," @10
: Cross – Reaction * & * (c
: 1 I $ < F,; , 10 Antigen ,- < N 58
. (15 8 8 ,( 156 ,; +)

. Long Act Thyroid Stimulating Factor 9

. 1 E , #M- / < 1 " , N , 10

- B> -
 (1) Immunology : General Principles . 2008 .

: 58
. - ] @ : - I $ < F,; , : , " : ,- , ,-. •
. _ , @7 @ , @ ,- g 10 + , ] > •
: Breakdown of tolerance & * / * (d
. 1 . 8) 51 ) ) 9 ,@ . *7 1M (
: 58
. @84 E,6 (#M- A 0 N ,) Hydralazine *> 1, 7 •
. @ @7 GN-Nzdmice , * 19< 1< •

" L " . =1- ; 7

0 ; 9 <

B cell white blood cell: a white blood cell lymphocyte, formed in bone marrow in mammals and present
in blood and lymph, that creates antibodies in response to a specific antigen .
T cell lymphocyte from thymus: a white blood cell lymphocyte that matures in the thymus and is
essential for various aspects of immunity, especially in combating viral infections and cancers.
Innate complement , neutrophils , alveolar macrophages , NK cells, IFN, normal flora, lysozyme,
• not specific • no memory .
Aquired a) cell mediated immunity b) antibody mediated • highly specific .

- -